Health

Massachusetts Gov. Maura Healey signed a bill Monday that may ensure all breast cancer screenings are covered by insurance, improving access across the state.

Currently, only annual mammograms are covered by insurance. In the U.S., about 10 to 12% of girls are called back for further testing after a mammogram, and these additional diagnostic tools not covered by insurance can cost a whole lot or 1000’s of dollars out of pocket.

The bill, a Medically Necessary Breast Examination and Screening Act for Equality and Early Detection, will eliminate these costs and associated barriers. By 2026, based on a press releasePatients have access to cancer screenings and tests without incurring out-of-pocket costs. Insurers must cover the price of breast cancer diagnostic tests, digital breast tomosynthesis screening (DBT), and breast MRIs and ultrasounds.

By stopping patient cost-sharing from increasing, the laws ensures that each one patients who need more rigorous testing have access to it, no matter their financial situation.

“This legislation will help ensure that cost is not a barrier to women getting the screenings and care they need,” Healey said in the discharge.

Between 2016 and 2020, there have been about 136 recent cases of breast cancer per 100,000 women in Massachusetts, barely higher than the national average of 129 per 100,000 women. based on the Susan G. Komen Foundation. In 2024 American Cancer Society estimates There might be 7,150 recent cases of breast cancer in women in Massachusetts, 730 of which might be fatal.

Susan G. Komen estimates that the breast cancer mortality rate for girls is 16 per 100,000 women, with rates increasing because the cancer progresses. Women diagnosed with stage 1 localized breast cancer have a 5-year relative survival rate of 99%. However, by stage 4, the 5-year survival rate is barely 31%, meaning 69% will die inside five years of diagnosis. based on the American Cancer Society.

“Early detection of breast cancer saves lives,” Sen. Joan Lovely (D-Salem), one among the bill’s sponsors, said within the press release. “This legislation makes early detection diagnostic testing accessible and affordable, giving women the vital resources they need to detect early-stage breast cancer.”

The bill received statements of support from Benjamin L. Ebert, MD, PhD, president and CEO of the Dana-Farber Cancer Institute, and Meredith Mendelson, executive director of the Ellie Fund, a Massachusetts nonprofit that fights breast cancer and provides free services for breast cancer cancer patients and families.

“We know that when health insurance plans cover medically necessary screenings and diagnostic breast imaging, we can detect breast cancer at an earlier stage, which can make a tremendous difference in outcomes,” Ebert said in a press release.

Dana- Farber, which has been driving its mobile mammography van to underserved neighborhoods in Boston and surrounding communities to perform mammograms since 2002, has long been committed to improving access to health look after all. The MA Radiological Society, the American Cancer Society's Cancer Action Network (ASC CAN), the Susan G. Komen Foundation, and Massachusetts hospitals and community health centers worked together to advocate for the passage of this laws.

Although initiatives corresponding to the mobile mammography cart have made progress in helping women get initial screenings, the price of follow-up screenings when vital often ends in a delay in treatment, which impacts mortality. Although white and black women are diagnosed with breast cancer at similar rates, the mortality rate is 40% higher for black women, based on Dana-Farber.

“Despite the fact that breast cancer mortality rates have been declining for several decades, not all people have benefited equally from the advances in prevention, early detection and treatment that have contributed to these lower rates,” says Marc Hymovitz, director of presidency relations in Massachusetts for the ASC CAN, said in a press release. “Removing cost barriers is one step toward eliminating these inequalities.”

Breastfeeding is one in all the largest challenges for a young mother returning to work within the United States

Typically, this involves bringing a breast pump to work, making day trip of your busy schedule to pump milk every few hours, and cleansing and putting away the pump after each use.

“What if, to order a cup of coffee, you had to pack your coffee machine in the morning, take it to work, put it in a travel bag, go into a small closet, take off your clothes, set up the coffee machine and make the coffee? And then do that three or four times over the course of the rest of the day,” says Patrice Meagher, founder and CEO of MilkMate, a startup specializing in workplace breastfeeding spaces.

MilkMate claims to have developed a way that may shorten each pumping session by quarter-hour. For working moms who must pump around thrice a day along with their work, this could mean a saving of as much as 23 working days a yr.

Employers resembling real estate developer Hines, law firm Blank Rome and Dartmouth College already use MilkMate to support breastfeeding parents.

The concept is easy: MilkMate installs its U.S. Food and Drug Administration-approved community breast pumps together with a cupboard stuffed with sterilized kits which can be intended for private use and might be discarded after each use. Milk collection and pumping mechanisms are separate to stop cross-contamination. A mother can simply are available, get a kit, pump, and begin pumping. There is not any washing or sterilizing of parts required, and no must lug a pump into the office.

“It makes it easier for people to come into the office and be more productive,” says Whitney Burns, senior vp of world client strategy at Hines, who worked with MilkMate to integrate the service into the true estate company’s coworking space at 205 Hudson in New York City.

In the U.S., about seven in 10 employees will not be eligible for parental leave, and even those moms who do have parental leave typically have much shorter vacation time than in Canada and lots of European countries. This signifies that these parents can have to return to work while still breastfeeding, which requires them to pump milk often. The U.S. Centers for Disease Control and Prevention recommends exclusive breastfeeding for the primary six months of a baby's life, and lots of moms proceed to breastfeed for several months after they begin solids.

Although there are not any official figures on what number of parents within the United States are employed, last yr there have been 5.6 million working moms with children ages one and under.

In a 2023 survey of 1,000 moms, 31% said they hadn't met their breastfeeding goals because they’d to return to work. Research shows that a scarcity of workplace resources, resembling a dedicated pumping space or adequate breaks, can force a mother to stop breastfeeding earlier or increase her stress.

If MilkMate is well received by users, Hines may roll it out to other locations, Burns said, adding that the system offers a competitive advantage for industrial properties.

In 2022, the U.S. law often called the PUMP for Nursing Mothers Act expanded moms' rights and required employers to provide employees time to pump milk outside of restrooms, giving about 9 million more employees that protection—and forcing even smaller employers to supply accommodations.

MilkMate pump users pay nothing; either the owner or employer covers the bill. Initial consultation, training and installation of the MilkMate device costs roughly $4,000 to $9,000 and ongoing service costs a mean of $5,000 per yr.

Dartmouth's Tuck School of Business will roll out MilkMate's service on its campus in the approaching weeks to alleviate a “stressful logistical challenge” for breastfeeding moms, Paul Mutone, the college's associate dean for finance and administration, said in an email.

MilkMate sees opportunities to expand beyond traditional office spaces, for instance in hospitals, hotels and manufacturing centers.

The New York-based company isn't the just one attempting to improve the work environment for brand new moms. Startup Work & Mother is establishing shared breastfeeding rooms in corporate buildings. And Nessel, whose clients include Tesla Inc. and PwC, offers portable sinks and soundproof breastfeeding booths.

As MilkMate's Meagher put it: “How do you make working parents' lives easier? By giving them more minutes back.”

___

©2024 Bloomberg LP Visit bloomberg.com. Distributed by Tribune Content Agency, LLC.

Originally published: September 12, 2024 at 1:14 p.m.

What is breast density and why is it vital?

Breast density is split into 4 categories: fatty tissue, scattered tissue, heterogeneous density, or extremely dense.

Dense breasts consist more of connective tissue and glandular tissue—that’s, glands that produce milk and tubes that transport it to the nipple—than of fatty tissue. Because each fibroglandular tissue and breast masses appear white on mammogram images, higher breast density makes cancer tougher to detect. Almost half of all American women are categorized as women with dense breast tissue.

Dense breasts also increase the danger of developing breast cancerHowever, the explanation for that is unknown.

This makes decisions about breast cancer screening more complicated. There is evident evidence that regular mammograms save livesWomen with dense breast tissue may require additional tests equivalent to ultrasound, MRI or contrast mammography.

What does the brand new FDA rule say?

The FDA now requires specific wording to make sure that all women receive the identical “accurate, complete, and understandable information about breast density.” After a mammogram, women should be informed about:

– Whether her breasts are dense or not

– The Dense breasts increase the danger of breast cancer

– That dense breasts makes it difficult to detect breast cancer in mammograms

– That additional imaging techniques could help detect cancer in women with dense breast tissue

You also needs to be advised to debate your individual situation together with your doctor to find out whether and, if that’s the case, which additional screening tests may be appropriate.

Why did the FDA issue the brand new rule?

Before the federal regulation 38 US states required some type of reporting of breast densityHowever, some states had no reporting requirement, and amongst others There were many disagreements The Concerns expressed by supportersincluding women with dense breast tissue whose advanced cancer was not detected by mammography.

The FDA has standardized the knowledge women must receive, written at an eighth-grade reading level and in a position to address racial and academic differences in women's knowledge of breast density and their responses to written communications.

Our research team found disproportionately more confusion and fear amongst women of color, women with low literacy skills, and girls whose first language was not English. And some women with low literacy skills reported that they might be less willing to undergo mammography screening in the longer term.

What is the good thing about additional tests?

Traditional mammograms use X-rays to create two-dimensional images of the breast. A more moderen kind of mammogram, called Tomosynthesis creates 3D images that Find more cancers in women with dense breast tissueTherefore, researchers and physicians generally agree that girls with dense breast tissue should undergo tomosynthesis screening every time possible.

There remains to be little scientific evidence to support recommendations for added breast cancer screening beyond standard mammography or tomosynthesis for ladies with dense breast tissue. Data show that additional screening with Ultrasonic, Magnetic resonance imaging or Contrast-enhanced mammography This may detect additional cancers, but there are not any prospective studies confirming that such additional screening saves more lives.

To date, there are not any data from randomized clinical trials demonstrating that supplemental breast MRI—essentially the most commonly advisable complementary screening test—reduces mortality from breast cancer.

However, more early stages – but not late stages – Cancers are detected with MRIswhich can require less extensive surgery and fewer chemotherapy.

Different skilled associations and experts interpret the available data on supplementary screening in another way and reach different conclusions and proposals. An vital consideration is the girl's individual risk, as recent evidence suggests that girls whose personal risk of developing breast cancer is high are most probably to learn of additional screenings.

Some organizations concluded that The current evidence is just too limited To make a suggestion for added screeningor they don’t recommend routine additional screening tests for ladies based solely on breast densityOther recommend additional screening for ladies with extremely or unevenly dense breasts, even when their risk is moderate.

What should women consider regarding additional preventive examinations?

Since personal breast cancer risk is a key think about deciding whether to undergo additional screening, women should know their very own risk.

The American College of Radiology recommends that every one women undergo a risk assessment by age 25. Women and their doctors can use risk calculators equivalent to Tyrer-Cuzick, which free and available online.

Women also needs to understand that breast density is barely certainly one of several risks for breast cancer and a number of the others may be modified. Regular physical activity, a healthy weight, limited alcohol consumption and a healthy weight-reduction plan with a lot of vegetables can all reduce the danger of breast cancer.

Is there potential damage?

In the midst of the Debate in regards to the advantages of additional breast cancer screeningThere is less discussion in regards to the possible damage. The commonest are false alarms: Results that suggest cancer and require follow-up tests. In rarer cases, a biopsy is required, which can lead to short-term anxiety and worry, medical bills, or possible complications from procedures.

Additional preventive examinations also can result in overdiagnosis and overtreatment – the small risk of detecting and treating a cancer that will never have been an issue.

MRI screening also uses a chemical substance that Gadolinium to enhance imaging. Although tiny amounts of gadolinium remain within the body, the FDA considers the Contrast agents for safety when administered to patients with normal renal function.

MRIs also can reveal incidental findings outside the breast – equivalent to within the lungs – that require additional attention, testing and costs. Women should weigh their willingness to take these risks against their desire for added screening.

The costs of additional examinations beyond mammography must even be taken into consideration; only 29 states and the District of Columbia Insurance coverage required for added breast cancer screeningsand only three states – New York, Connecticut and Illinois – require insurance coverage without copayment.

How are you able to discover more?

Although the FDA encourages women to talk over with their doctors, our research found that only few women have such conversations and that Many providers lack sufficient knowledge about breast density and current guidelines for breast cancer screening.

It is just not yet clear why, but providers receive little or no training on breast density and report little Confidence in a single’s own ability to advise patients on this topic.

To address this data gap in some health care settings, radiologists, whose screening policies are more stringent than those of another organizations, sometimes provide a suggestion for added screening as a part of their mammography report back to the physician who ordered the mammogram.

Educating a girl in regards to the topic before chatting with a physician will help her higher understand her options.

Numerous online resources provide further information, including the American Cancer Society, the web site Dense Breast-Info and the American College of Radiology.

Armed with information in regards to the complexity of breast density and its impact on breast cancer screening, women can discuss their personal risk with their doctors and explore options for added screening, making an allowance for how they perceive the advantages and harms of various tests.

All mammals have Mammary glands that produce milka feature that has fascinated scientists for a few years. Questions similar to why mammary glands evolved in the primary place, how they adapted to different species, and what unique evolutionary pressures shaped their development remain largely unanswered.

To investigate how different species have evolved unique solutions to biological challenges, my team on Rauner Laboratory the Tufts University School of Medicine is Recreating mammal diversity in a bowl through miniature versions of mammary glands – organoids. These models can provide information concerning the basic biological processes behind milk production, tissue regeneration and the early stages of breast cancer development.

What are organoids?

Organoids are Miniature 3D structures grown in a cell culture dish that mimics the structure and performance of real organs. These models are created by targeting stem cells, which have the unique ability to distinguish into different cell types, to supply specific organ cell types.

Although organoids will not be exact miniature replicas of full-size organs, they contain enough cells and tissue architecture to duplicate the environment and key functions of the organ they’re modeling. For example: Mammary gland organoid or breast tissue organoid consist of tiny, elongated ducts that end in a spherical structure and mimic the milk ducts and alveoli of the glandular tissue.

Organoids are a strong tool for biomedical research because they supply a 3D representation of an organ's structure and performance. Unlike traditional 2D cell cultures, organoids can mimic the complexity of real tissues, including their architecture and distinct cell types. This allows researchers to review complex biological processes similar to tissue development, regeneration and disease progression in a controlled environment while reducing reliance on animal models.

Mammal diversity on one plate

Researchers have traditionally Organoids used to model human diseases, test drugs and study developmental biology. However, their potential goes far beyond these applications, especially in the sector of Evolutionary biology.

My research focuses on the generation of mammary gland organoids from various mammalian species. Mammals are incredibly diverse, with each species adapted to a wide range of environments and lifestyles. The mammary gland, which is crucial for rearing offspring, has significant differences between species.

For example, Monotremes similar to platypus and echidna belong to a novel and ancient class of mammals. Monotremes split off from other groups of mammals about 190 million years ago and are distinguished by their reproductive methods: they lay eggs quite than give birth to live offspring. Their mammary glands are quite different from those of eutherian mammals similar to cows and humans, which have nipples; monotremes secrete milk through special milk hairs as a substitute.

Scientists consider that different environmental stresses and reproductive strategies Development of various types of lactationHowever, the precise mechanisms and evolutionary pathways are still largely unknown. By comparing organoids from these different species, researchers can make clear how these ancient structures have evolved and adapted over tens of millions of years to fulfill the reproductive needs of various animals.

Insights beyond the mammary gland

Studying the unique properties of the mammary gland also can provide insights into other areas of biology and medicine.

For example, the mammary gland is capable of regenerate with each cycle reproduction and lactation. This makes it a superb Model for studying tissue regenerationWith organoids, researchers can Observe the means of regeneration in real time and study how different species have evolved to take care of this regenerative capability. Understanding the mechanisms behind regeneration could lead on to advances in Regenerative Medicinea field that focuses on repairing or replacing damaged tissues and organs in conditions similar to heart disease, diabetes, and injuries.

Breast organoids also can help with Breast cancer Research. Investigation of breast organoids of species that rarely develop breast tumorslike cows and pigs, could reveal possible protective mechanisms and develop recent strategies for breast cancer prevention and treatment. Organoids also provide a platform to review the early events of tumor formation and the cellular environment that contributes to cancer development.

Organoids also allow scientists to review the onset, duration and end of lactation in several species. The means of lactation varies greatly between mammalsinfluenced by aspects similar to hormonal changes and environmental conditions. Some mammals have unique types of lactation. For example, Marsupials similar to the Tammar Wallaby can produce two sorts of milk concurrently to fulfill the dietary needs of offspring at different stages of development, a phenomenon often known as asynchronous simultaneous lactation. Over and beyond fur seal can maintain lactation despite long periods without breastfeeding.

Studying different lactation types using breast organoids may provide deeper insights into the regulation of lactation and uncover evolutionary adaptations that would contribute to the understanding of the biology of human lactation and improve milk production strategies in farmed animals.

The potential of organoid technology

Organoids offer several benefits over traditional animal models. First, they supply a controlled environment for studying complex biological processes and permit scientists to perform multiple tests concurrently. Increasing research efficiency.

They also reduce the moral concerns related to animal testing. Organoids will be created from animals that not available for live researchsimilar to rare or endangered species.

In addition, organoids will be genetically modified to review specific genes and signaling pathways, thereby gaining deeper insights into the molecular mechanisms of mammary gland biology.

Organoids are an efficient tool, but they’re not without restrictions. They cannot fully replicate the complexity of living tissues, and findings from organoid studies should be validated in living subjects. Despite these hurdles, advances in organoid technology proceed to push the boundaries of what is feasible and offer recent opportunities to explore mammalian diversity and evolution.

By recreating the variety of mammalian tissue in a Petri dish, researchers can gain essential insights into how different species have evolved to unravel biological problems, which may benefit human health in addition to agriculture and dietary science.

Jackie Speier – the previous U.S. Congresswoman who represented California’s 14th district from 2008 to 2013 – has breast cancer.

The San Franciscan native, who was elected to the San Mateo County Board of Supervisors in March, made the news public via social media.

“I have personal news that I want to share with you because we can all learn from it. I just became one of 300,000 women diagnosed with breast cancer each year,” she posted on X (formerly generally known as Twitter) on July 4. “The good news is that it was caught early and I had a successful lumpectomy on Tuesday.”

She shared her experience within the hope of motivating other women to get screened for signs of breast cancer.

“Here's what happened: I had a mammogram in June 2023 and had an appointment for June of this year. I almost didn't go because of summer activities. Thank goodness I didn't cancel,” she continued in replies to her own original post. “I received excellent care from UCSF, surgeon Dr. Laura Esserman, radiologists Dr. Kimberly Ray and Dr. Alissa Price. The lesson here is, please be diligent in your own screenings and don't skip them.”

I actually have personal news that I need to share with you because we are able to all learn from it. I just became certainly one of 300,000 women diagnosed with breast cancer annually.
The excellent news is that it was discovered early and I had a successful lumpectomy on Tuesday.

— Jackie Speier (@RepSpeier) July 4, 2024

Speier's announcement was greeted with a gentle stream of congratulations and thanks from others on the X platform.

“Thank you for helping others by sharing your story, @RepSpeier. Wishing you a speedy recovery from your surgery and many years of continued health. It's been almost 8 years since my diagnosis of stage 3B breast cancer, and I'm doing well,” posted @KayeSteinsapir.

“Jackie, I'm so glad it was caught so early. Thank you for sharing this news with us. I'm waiting for my follow-up mammogram later this month after last month's 'not so great'. Your news gives me hope,” posted @newt50.

In addition to her time as a U.S. Congresswoman, Speier, a long-time member of the Democratic Party, can be known for her participation in a 1978 commission of inquiry that was tasked with investigating the activities of Jim Jones and his Peoples Temple followers in Jonestown, Guyana. The team was ambushed by an armed group of Jones followers, leading to the deaths of 5 people and multiple shots fired at Speier.

Did you recognize that casual drinks with friends or a “wine mom” moment to chill out can actually increase your risk of breast cancer? That appears like a mood killer. But it's a truth that many may not know: Alcohol actually causes breast cancer.

The World Health Organization and that National Institute on Alcohol Abuse and Alcoholism To put it bluntly, in comparison with individuals who don’t drink alcohol, only one alcoholic drink a day can increase your risk of breast cancer by 5 to 9%.

As Alcohol and Cancer researcherswe wanted to seek out out more about what women actually know in regards to the link between alcohol and breast cancer, especially since alcohol consumption increasingly in women.

Explanation of the knowledge gap

For our recently published study surveyed greater than 5,000 women 18-year-olds and older within the United States in 2021 about whether or not they are aware of the link between alcohol consumption and breast cancer. We also asked them about their drinking habits and other health and background aspects.

We were surprised that just one in 4 of those women knew that alcohol is a risk factor for breast cancer. Even more worrying is that 35% don’t imagine there may be any connection in any respect. An additional 40% were unsure about this.

We also saw a Knowledge gap based on age, education and race.

Younger, more educated women and people with alcohol-related problems were more aware of the link between alcohol and breast cancer risk than older, less educated women and people who had not drunk alcohol previously yr. Black women were also less aware of the danger between alcohol and breast cancer in comparison with white women.

Drinking less reduces the danger of breast cancer

Despite attempts by alcohol researchers, health authorities and advocates, Inform women in regards to the risks of alcohol and its association with breast cancer, our findings show that this message shouldn’t be getting through to most individuals.

There are also ubiquitous Myths in regards to the advantages of alcohol consumption because some people don’t want to know that alcohol might be harmful and don't need to discuss itFor this reason, many ladies are simply unaware or unsure in regards to the health damage attributable to alcohol.

A comprehensive communications approach to raising awareness of the risks of alcohol and its link to cancer can support and encourage women to make healthier decisions regarding their alcohol consumption.

Awareness campaigns can assist educate people from different backgrounds in regards to the risks of alcohol consumption and breast cancer.

Policy changes regarding the marketing, access and availability of alcohol can even make a difference in people's drinking habits.

These guidelines may apply to the “Feminization” of alcohol promotingwhich deliberately entices women drink and buy alcohol by normalizing or glorifying heavy drinking and ignoring the health risks and harms related to it. The World Health Organization recommends stricter rules against alcohol promoting and marketing and better taxes on alcohol to cut back alcohol-related harm.

Today's Culture can normalize Coping with on a regular basis stress by popping the cork.

But drinking less alcohol can reduce the danger of breast cancer. If you step back and give it some thought, Effects of alcohol in your health can show you how to make an informed decision about whether or to not drink.